The 2-13C-5-fluorouracil breath test (FUBT) as a novel, rapid method for assessment of dihydropyrimidine dehydrogenase (DPD) activity in cancer patients: Initial characterization and comparison to the 2-13C-uracil breath test (UraBT)

被引：0
|
作者：
Fourie, J.
Mattison, L. K.
Wood, T. E.
Posey, J. A., III
Modak, A.
Diasio, R. B.
机构：
[1] Mayo Clin, Ctr Canc, Rochester, MN USA
[2] Univ Alabama Birmingham, Birmingham, AL USA
[3] Cambridge Isotope Labs Inc, Cambridge, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2551
引用
收藏
页数：1
相关论文
共 25 条
  • [11] Describing the catabolism of orally administered 2-13C-uracil in normal and dihydropyrimidine dehydrogenase deficient subjects using a parent/metabolite/breath model.
    Mattison, LK
    Acosta, EP
    Fourie, J
    Diasio, RB
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P83 - P83
  • [12] A novel one-hour 13C-sorbitol breath test versus the H2-sorbitol breath test for assessment of coeliac disease
    Tveito, Kari
    Hetta, Anne Kristine
    Askedal, Mia
    Brunborg, Cathrine
    Sandvik, Leiv
    Loberg, Else Marit
    Skar, Viggo
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2009, 44 (07) : 813 - 819
  • [13] A novel one-hour 13C-sorbitot breath test versus the H2-sorbitol breath test for assessment of coeliac disease
    Tveito, Kari
    Hetta, Anne Kristine
    Askedal, Mia
    Brunborg, Cathrine
    Sandvik, Leiv
    Loeberg, Else Marit
    Skar, Viggo
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2009, 44 : 52 - 52
  • [14] Rapid Identification of the Hepatic Cytochrome P450 2C19 Activity Using a Novel and Noninvasive [13C]Pantoprazole Breath Test
    Desta, Zeruesenay
    Modak, Anil
    Nguyen, Phuong D.
    Lemler, Suzanne M.
    Kurogi, Yasuhisa
    Li, Lang
    Flockhart, David A.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 329 (01): : 297 - 305
  • [15] Further characterization of a 13C-dextromethorphan breath test for CYP2D6 phenotyping in breast cancer patients on tamoxifen therapy
    Opdam, F. L.
    Modak, A. S.
    Gelderblom, H.
    Guchelaar, H. J.
    JOURNAL OF BREATH RESEARCH, 2015, 9 (02)
  • [16] Rapid identification of hepatic CYP2C19 activity using the [13C]-pantoprazole breath test in healthy volunteers genotyped for CYP2C19.
    Desta, Z.
    Nguyen, P. D.
    Lemler, S. M.
    Flockhart, D. A.
    Modak, A.
    Kurogi, Y.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S19 - S20
  • [17] ASSESSMENT OF CYP1A2 ENZYME BY 13C METHACETIN BREATH TEST IN RELATION TO HEPATIC IRON OVERLOAD IN PATIENTS WITH β-THALASSEMIA
    Shteyer, Eyal
    Itamar, Nitzan
    Goldfarb, Ada
    Hemed, Nilla
    Revel-Vilk, Shoshana
    HEPATOLOGY, 2011, 54 : 521A - 521A
  • [18] Methodological characterization of the 2-keto[1-13C]isocaproate breath test to measure in vivo human mitochondrial function:: Application in alcoholic liver disease assessment
    Parra, D
    González, A
    García-Villarreal, L
    Martínez, JA
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2003, 27 (08) : 1293 - 1298
  • [19] The effect of proton pump inhibitors on the CYP2C19 enzyme activity evaluated by the pantoprazole-13C breath test in GERD patients: clinical relevance for personalized medicine
    Modak, Anil S.
    Klyarytska, Iryna
    Kriviy, Valerij
    Tsapyak, Tatjana
    Rabotyagova, Yliya
    JOURNAL OF BREATH RESEARCH, 2016, 10 (04)
  • [20] 13CO2 excretion in breath of normal subjects and cirrhotic patients after 13C-aminopyrine oral load.: Comparison with MEGX test in functional differentiation between chronic hepatitis and liver cirrhosis
    Fasoli, A
    Giannini, E
    Botta, F
    Romagnoli, P
    Risso, D
    Celle, G
    Testa, R
    HEPATO-GASTROENTEROLOGY, 2000, 47 (31) : 234 - 238
123